Stelo is Dexcom's over-the-counter glucose biosensor for adults not on insulin.
Competing Products
Dexcom
Dexcom, Inc.: A San Diego-based medical device company specializing in continuous glucose monitoring systems for diabetics.
Founded
1999Dexcom, Inc.: A San Diego-based medical device company specializing in continuous glucose monitoring systems for diabetics.
Founded in San Diego, California, Dexcom, Inc. is a medical device company dedicated to improving the lives of people with diabetes through innovative continuous glucose monitoring (CGM) systems. The company's core mission is to provide real-time glucose monitoring to help users manage their diabetes more effectively. Dexcom's flagship products include the Dexcom G6 and the recently launched Dexcom G7, which offer advanced features such as direct-to-Apple Watch connectivity and enhanced accuracy. The company targets the diabetic population, aiming to simplify diabetes management and improve health outcomes.
Dexcom has garnered support from notable investors and has established itself as a leader in the CGM market. The company's achievements include receiving FDA approvals for its devices and expanding its product availability globally. Dexcom's impact is significant, as its technology allows for better glucose management, reducing complications associated with diabetes. Through continuous innovation and a strong commitment to user experience, Dexcom has made a profound difference in the lives of diabetics worldwide.
Companies similar to Dexcom include Tab0, Glysens, Glumetrics and Tandem Diabetes Care.
Dexcom was founded in 1999.
Dexcom's headquarters is located in San Diego, CA, US.
Dexcom's most recent funding round was for $1B (USD) in May 2023.
As of May 2, 2023, Dexcom has disclosed funding of $1.4B (USD). Undisclosed round amounts are excluded.
Dexcom has 7,600 employees as of Feb 6, 2024.
tandemdiabetes.com